Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

A multimodal machine learning framework to predict treatment duration in multiple myeloma patients

Frederick Shi, Xinyi Yang, Juan Li, Shijing Wang, Bin Sun, Jing Dong, Peiman Hematti, Siegfried Janz, Anita D'Souza, Laura Michaelis, Binod Dhakal, Fumou Sun

Blood (2025) 146 (Supplement 1): 5715.

https://doi.org/10.1182/blood-2025-5715

Published: 2025

Journal Articles

Cell-free CAR therapy: BCMA-CAR-T cell-derived exosomes exhibit potent anti-myeloma activity

Bin Sun, Shijing Wang, Ali Ishaq, Deepak Parashar, Sridhar Rao, Tyce Kearl, Jing Dong, Peiman Hematti, Siegfried Janz, Binod Dhakal, Fumou Sun

Blood (2025) 146 (Supplement 1): 2159.

https://doi.org/10.1182/blood-2025-2159

Published: 2025

Journal Articles

Intelligent bispecific BCMA-CD24 CAR-T cells for precision navigation and elimination of multiple myeloma

Shijing Wang, Bin Sun, Ali Ishaq, Deepak Parashar, Sridhar Rao, Tyce Kearl, Jing Dong, Peiman Hematti, Siegfried Janz, Binod Dhakal, Fumou Sun

Blood (2025) 146 (Supplement 1): 800.

https://doi.org/10.1182/blood-2025-800

Published: 2025

Journal Articles

CLPTM1L: A candidate therapeutic target in multiple myeloma

Swadha Pandey, Sandhya Rai, Ansul Sharma, Aishwarya Sharma, Saurabh Gupta, Fumou Sun, Amit Mitra, Jing Dong, Sridhar Rao, Binod Dhakal, Michael James, Siegfried Janz, Deepak Parashar

Blood (2025) 146 (Supplement 1): 7457.

https://doi.org/10.1182/blood-2025-7457

Published: 2025

Journal Articles

Computational Structural Genomics Meets Cryo-EM for the Analyses of Mitochondria-Encoded Enzyme Complexes: A Transformational Approach for Deep Variant Phenotyping in Myelodysplastic Neoplasms

Jing Dong, Michael T. Zimmermann, Wael Saber, Raul Urrutia

Blood (2024) 144 (Supplement 1): 1058.

https://doi.org/10.1182/blood-2024-193462

Published: 2024

Journal Articles

Activation-Inducible Bispecific BCMA-CD24 CAR-T Cells Precisely and Safely Control Multiple Myeloma Growth

Fumou Sun, Jing Dong, Peiman Hematti, Siegfried Janz, Binod Dhakal

Blood (2024) 144 (Supplement 1): 4791.

https://doi.org/10.1182/blood-2024-205476

Published: 2024

Journal Articles

Genome-Wide Association Study Identifies Novel Loci Associated with Survival in Multiple Myeloma

Remy Lee, Shahram Arsang-Jang, Anita D'Souza, Binod Dhakal, Siegfried Janz, Jing Dong

Blood (2024) 144 (Supplement 1): 4719.

https://doi.org/10.1182/blood-2024-201795

Published: 2024

Journal Articles

Does Socioeconomic Status Have an Impact on Light Chain (AL) Amyloidosis Disease Characteristics and Outcomes?

Mingqian Lin, Aniko Szabo, Liliana Pezzin, Jing Dong, Binod Dhakal, Meera Mohan, Ravi Narra, Marcelo Pasquini, Anita D'Souza

Blood (2023) 142 (Supplement 1): 4783.

https://doi.org/10.1182/blood-2023-186740

Published: 2023

Journal Articles

Prognostic Impact and Landscape of Mitochondrial DNA Variants in Myelodysplastic Syndromes Undergoing Allogenic Hematopoietic Cell Transplantation

Jing Dong, Christopher Staffi Buradagunta, Tao Zhang, Stephen R. Spellman, Yung-Tsi Bolon, Paul Auer, Wael Saber

Blood (2022) 140 (Supplement 1): 6930–6931.

https://doi.org/10.1182/blood-2022-159738

Published: 2022

Journal Articles

Association of Human Leukocyte Antigen Variants with Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Ben Massat, Gokul Pareek, Christopher Staffi Buradagunta, Bicky Thapa, Paul Auer, Binod Dhakal, Siegfried Janz, Parameswaran Hari, Jing Dong

Blood (2022) 140 (Supplement 1): 10063–10064.

https://doi.org/10.1182/blood-2022-160086

Published: 2022

Journal Articles

Impaired Plasma B Cell Markers in CD138+ Cells Predict Prognosis in Multiple Myeloma

Jing Dong, Jian-Rong Li, Christopher Staffi Buradagunta, Siegfried Janz, Raul Urrutia, Chao Cheng

Blood (2022) 140 (Supplement 1): 10054–10055.

https://doi.org/10.1182/blood-2022-158718

Published: 2022

Journal Articles

Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Lindsay Hammons, Shabi Haider, Marcelo C Pasquini, Saurabh Chhabra, Sabarinath Radhakrishnan, Anthony E. Zamora, Meera Mohan, Jing Dong, Siegfried Janz, Anita D'Souza, Parameswaran Hari, Binod Dhakal

Blood (2022) 140 (Supplement 1): 7215–7216.

https://doi.org/10.1182/blood-2022-165483

Published: 2022

Journal Articles

Characteristics Associated with Disparities in Survival between Hispanic and Non-Hispanic White Patients with Multiple Myeloma: A Matched Cohort Study

Jing Dong, Zhuping Garacci, Christopher Staffi Buradagunta, Meera Mohan, Anita D'Souza, Ashley Cunningham, Siegfried Janz, Binod Dhakal, Parameswaran Hari

Blood (2021) 138 (Supplement 1): 4091.

https://doi.org/10.1182/blood-2021-148880

Published: 2021

Journal Articles

Gene expression–based classification and regulatory networks of pediatric acute lymphoblastic leukemia

Zhigang Li, Wei Zhang, Minyuan Wu, Shanshan Zhu, Chao Gao, Lin Sun, Ruidong Zhang, Nan Qiao, Huiling Xue, Yamei Hu, Shilai Bao, Huyong Zheng, Jing-Dong J. Han

Blood (2009) 114 (20): 4486–4493.

https://doi.org/10.1182/blood-2009-04-218123

Published: 2009

Includes: Supplemental data

Journal Articles

MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4

Qiang Wang, Zheng Huang, Huiling Xue, Chengcheng Jin, Xiu-Li Ju, Jing-Dong J. Han, Ye-Guang Chen

Blood (2008) 111 (2): 588–595.

https://doi.org/10.1182/blood-2007-05-092718

Published: 2008

Journal Articles

MCP-1 mediates TGF-β–induced angiogenesis by stimulating vascular smooth muscle cell migration

Jing Ma, Qiang Wang, Teng Fei, Jing-Dong Jackie Han, Ye-Guang Chen

Blood (2006) 109 (3): 987–994.

https://doi.org/10.1182/blood-2006-07-036400

Published: 2006

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A multimodal machine learning framework to predict treatment duration in multiple myeloma patients

Cell-free CAR therapy: BCMA-CAR-T cell-derived exosomes exhibit potent anti-myeloma activity

Intelligent bispecific BCMA-CD24 CAR-T cells for precision navigation and elimination of multiple myeloma

CLPTM1L: A candidate therapeutic target in multiple myeloma

Computational Structural Genomics Meets Cryo-EM for the Analyses of Mitochondria-Encoded Enzyme Complexes: A Transformational Approach for Deep Variant Phenotyping in Myelodysplastic Neoplasms

Activation-Inducible Bispecific BCMA-CD24 CAR-T Cells Precisely and Safely Control Multiple Myeloma Growth

Genome-Wide Association Study Identifies Novel Loci Associated with Survival in Multiple Myeloma

Does Socioeconomic Status Have an Impact on Light Chain (AL) Amyloidosis Disease Characteristics and Outcomes?

Prognostic Impact and Landscape of Mitochondrial DNA Variants in Myelodysplastic Syndromes Undergoing Allogenic Hematopoietic Cell Transplantation

Association of Human Leukocyte Antigen Variants with Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

Impaired Plasma B Cell Markers in CD138+ Cells Predict Prognosis in Multiple Myeloma

Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Characteristics Associated with Disparities in Survival between Hispanic and Non-Hispanic White Patients with Multiple Myeloma: A Matched Cohort Study

Gene expression–based classification and regulatory networks of pediatric acute lymphoblastic leukemia

MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4

MCP-1 mediates TGF-β–induced angiogenesis by stimulating vascular smooth muscle cell migration

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only